JOHN SAURINO, DO
Ophthalmology Physician · TULSA, OK
Individual Active NPI 1245274117
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,508 | 29,891 | $7,356,350 | $2,942,995 | $2,288,922 |
| 2023 | 1,488 | 24,017 | $7,152,716 | $2,873,665 | $2,233,740 |
| 2022 | 1,468 | 25,812 | $8,105,736 | $3,267,812 | $2,551,016 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 8,760 | $35 | $28 |
| J3396 | Injection, verteporfin, 0.1 mg | 4,688 | $11 | $9 |
| 92134 | Imaging of retina | 3,179 | $37 | $28 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 3,069 | $14 | $11 |
| 67028 | Injection of drug into eye | 2,045 | $103 | $76 |
| 92012 | Established patient problem focused exam of visual system | 2,012 | $81 | $57 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,440 | $331 | $264 |
| J0178 | Injection, aflibercept, 1 mg | 1,168 | $822 | $653 |
| J9035 | Injection, bevacizumab, 10 mg | 996 | $72 | $55 |
| 92014 | Established patient complete exam of visual system | 823 | $115 | $78 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 414 | $153 | $108 |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 372 | $322 | $255 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 2901 | OK |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Oklahoma
- NPI 1972955367
- NPI 1922107648
- NPI 1982838397
- NPI 1770778839
- NPI 1154351310
- NPI 1538162367
- NPI 1588795629
- NPI 1396754644
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.